Mathilde Vincent
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Mathilde Vincent has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
Adrian R. Krainer
Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, USA
1 shared publicationAnastasia Ashkinadze
Institute of Pharmaceutical Sciences, ETH Zurich, Zurich, Switzerland
1 shared publication- Angel E. Santorelli
Institute of Pharmaceutical Sciences, ETH Zurich, Zurich, Switzerland
1 shared publication - Berk Kocar
F. Hoffmann-La Roche AG, Grenzacherstrasse 24, CH-4070 Basel, Switzerland
1 shared publication Christian Bell
F. Hoffmann-La Roche AG, Grenzacherstrasse 24, CH-4070 Basel, Switzerland
1 shared publicationChristoph Paschen
F. Hoffmann-La Roche AG, Grenzacherstrasse 24, CH-4070 Basel, Switzerland
1 shared publication
Latest Publications
- Open Access
- 13 November 2026
- Published by SAGE Publications in Nucleic Acid Therapeutics
Properties of Stereodefined Variants of Nusinersen
In the pharmaceutical industry, stereopure drugs are generally preferred over isomeric mixtures to reduce the risks of side effects and to simplify pharmacodynamics (PD) and pharmacokinetics (PK) properties. This reasoning applies equally to antisense oligonucleotides (ASOs). All current ASO drugs are modified to provide appropriate PK/PD properties. Among the modifications, phosphorothioate (PS) groups provide essential nuclease resistance and advantageous biodistribution properties. However, PS groups are chiral, with R p- and S p-centers that are challenging to incorporate stereoselectively during solid-phase synthesis, and thus current ASO drugs are diastereoisomeric mixtures. Here, we describe the synthesis of stereodefined variants of the approved drug nusinersen (Spinraza), a 2′- O -methoxyethyl-modified oligonucleotide that redirects splicing of SMN2 during treatment for spinal muscular atrophy (SMA). We found that a single 3′- S p linkage stabilizes nusinersen from degradation in mouse tissue homogenates. Although R p-nusinersen has higher target-binding affinity than S p-nusinersen, it is not more active than parent nusinersen in patient-derived cells. Finally, we show mixed results from comparing stereodefined nusinersen with parent nusinersen in a murine model of SMA. While our data do not provide definitive evidence for the superior performance of stereodefined nusinersen, we conclude that it is likely equally effective as its parent ASO, while bearing the pharmacological advantages of a single stereoisomer.
- 13 November 2026
- Published by SAGE Publications in Nucleic Acid Therapeutics
Open AccessProperties of Stereodefined Variants of Nusinersen
In the pharmaceutical industry, stereopure drugs are generally preferred over isomeric mixtures to reduce the risks of side effects and to simplify pharmacodynamics (PD) and pharmacokinetics (PK) properties. This reasoning applies equally to antisense oligonucleotides (ASOs). All current ASO drugs are modified to provide appropriate PK/PD properties. Among the modifications, phosphorothioate (PS) groups provide essential nuclease resistance and advantageous biodistribution properties. However, PS groups are chiral, with R p- and S p-centers that are challenging to incorporate stereoselectively during solid-phase synthesis, and thus current ASO drugs are diastereoisomeric mixtures. Here, we describe the synthesis of stereodefined variants of the approved drug nusinersen (Spinraza), a 2′- O -methoxyethyl-modified oligonucleotide that redirects splicing of SMN2 during treatment for spinal muscular atrophy (SMA). We found that a single 3′- S p linkage stabilizes nusinersen from degradation in mouse tissue homogenates. Although R p-nusinersen has higher target-binding affinity than S p-nusinersen, it is not more active than parent nusinersen in patient-derived cells. Finally, we show mixed results from comparing stereodefined nusinersen with parent nusinersen in a murine model of SMA. While our data do not provide definitive evidence for the superior performance of stereodefined nusinersen, we conclude that it is likely equally effective as its parent ASO, while bearing the pharmacological advantages of a single stereoisomer.
- Open Access
- 15 August 2023
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 236, 115651
Leveraging mass detection to simultaneously quantify surfactant content and degradation mode for highly concentrated biopharmaceuticals
- 15 August 2023
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 236, 115651
Open AccessLeveraging mass detection to simultaneously quantify surfactant content and degradation mode for highly concentrated biopharmaceuticals
- 21 January 2019
- Published by Wiley in Magnetic Resonance in Chemistry
- Vol. 57 (9) , 589-602
Identification of markers of thermal processing (“roasting”) in aqueous extracts of Coffea arabica L. seeds through NMR fingerprinting and chemometrics
Roasting of Coffea arabica L. seeds gives rise to chemical reactions that produce more than 800 compounds, some being responsible for the desired organoleptic properties for which the beverage called “coffee” is known. In the industry, the “roasting profile,” that is, the times and temperatures applied, is key to influence the composition of roasted coffee beans and the flavour of the beverage made from them. The impact of roasting on the chemical composition of coffee has been the subject of numerous studies, including by nuclear magnetic resonance (NMR) spectroscopy. However, the roasting equipment and profiles applied in these studies are often far from real industrial conditions.In this work, the effects of two critical technological parameters of the roasting process, namely, the “development time” (the period of time after the “first crack,” a characteristic noise due to seed disruption) and the final roasting temperature on coffee extracts, were investigated. Seeds were roasted at pilot scale according to 13 industrial roasting profiles and extracted in D2O. The extracts were analysed by 1H NMR experiments. The NMR spectra were compared using (a) quantitative analysis of main signals by successive orders of magnitude and (b) chemometric tools (principal component analysis, partial least squares and sparse‐orthogonal partial least squares analysis). This allowed to identify compounds, which may serve as markers of roasting and showed that changes in chemical composition can be detected even for slight change in final temperature (~1°C) or in total roasting time (~25 s).
- 21 January 2019
- Published by Wiley in Magnetic Resonance in Chemistry
- Vol. 57 (9) , 589-602
Identification of markers of thermal processing (“roasting”) in aqueous extracts of Coffea arabica L. seeds through NMR fingerprinting and chemometrics
Roasting of Coffea arabica L. seeds gives rise to chemical reactions that produce more than 800 compounds, some being responsible for the desired organoleptic properties for which the beverage called “coffee” is known. In the industry, the “roasting profile,” that is, the times and temperatures applied, is key to influence the composition of roasted coffee beans and the flavour of the beverage made from them. The impact of roasting on the chemical composition of coffee has been the subject of numerous studies, including by nuclear magnetic resonance (NMR) spectroscopy. However, the roasting equipment and profiles applied in these studies are often far from real industrial conditions.In this work, the effects of two critical technological parameters of the roasting process, namely, the “development time” (the period of time after the “first crack,” a characteristic noise due to seed disruption) and the final roasting temperature on coffee extracts, were investigated. Seeds were roasted at pilot scale according to 13 industrial roasting profiles and extracted in D2O. The extracts were analysed by 1H NMR experiments. The NMR spectra were compared using (a) quantitative analysis of main signals by successive orders of magnitude and (b) chemometric tools (principal component analysis, partial least squares and sparse‐orthogonal partial least squares analysis). This allowed to identify compounds, which may serve as markers of roasting and showed that changes in chemical composition can be detected even for slight change in final temperature (~1°C) or in total roasting time (~25 s).